Metabiomics
  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
Select Page

Metabiomics and Chinese Health Testing Leader Kindstar Global form Partnership to Develop a Microbiome and Next-Generation Sequencing-Based Screening Test for Colorectal Cancer

by Greg Kuehn | May 13, 2013 | Press Releases

PRESS RELEASE POTOMAC FALLS, VA., May 6, 2013 — Metabiomics Corporation and Kindstar Global, the leading specialty clinical testing laboratory in China, have signed a licensing and distribution deal for the development of the world’s first microbiome-based...
Metabiomics Selected to Present a Next-Generation Sequencing Cancer Diagnostics Strategy at Two Upcoming Investor Conferences

Metabiomics Selected to Present a Next-Generation Sequencing Cancer Diagnostics Strategy at Two Upcoming Investor Conferences

by Greg Kuehn | Oct 6, 2012 | Press Releases

  Metabiomics will describe its approach for developing a sequencing-based, non-invasive screening test for colorectal cancer at the Colorado Capital Conference and OCTANe Medical Device & Investor Forum   Potomac Falls, Virginia (October 5, 2012)...

New Metabiomics Screening Test for Early Detection and Prevention of Colorectal Cancer Poised to Reduce Health Care Costs and Save Lives

by Greg Kuehn | Sep 21, 2012 | Press Releases

Metabiomics Selected to Present Molecular Diagnostic Innovations and Growth Strategy at Annual Mid-Atlantic BIO Conference Potomac Falls, Virginia (September 17, 2012) Metabiomics, a Northern-VA-based molecular diagnostics firm, was selected by the Mid-Atlantic Bio...
Microbiome Biomarker and Diagnostic Patent Awarded by EPO

Microbiome Biomarker and Diagnostic Patent Awarded by EPO

by Greg Kuehn | Jun 21, 2012 | Press Releases, Research News

PRESS RELEASE World’s First Human Microbiome Patent for Diagnosis of Colon Disorders Awarded by European Patent Office Potomac Falls, Virginia – June 21, 2012:  Metabiomics® announced today that it has been awarded patent number EP 1815016 B1 titled “Compositions and...
New Health Sciences Frontiers in Metagenomics and the Human Microbiome

New Health Sciences Frontiers in Metagenomics and the Human Microbiome

by Greg Kuehn | Jun 15, 2011 | Press Releases, Research News

It is not often that health sciences takes off in leaps and bounds on a whole new branch of discovery. Systems Biology scientists are exploring the Metagenome and Microbiome of Humans to map their interactive genetic and metabolic functions.We define the complex...
« Older Entries
Next Entries »

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening March 20, 2020
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test December 17, 2019
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer September 5, 2019

Tag Cloud

Breakthrough Device China clinical studies colon cancer screening colon cancer test colon polyp Colorado Capital Conference colorectal adenoma colorectal cancer colorectal cancer diagnostics colorectal cancer screening CoreBiome Curtis Huttenhower Dan Knights Harvard Investor conference Keri Donaldson Kindstar LifeKit Prevent MB-01 MBAC Metabiomics Metagenomics Microbiome microbiome diagnostics microbiome sampling kit Mid-Atlantic Bio molecular diagnostics MultiTag Sequencing neoplasia Next-Generation Sequencing OCTANe Medical Device & Investor Forum Oricol Origin Sciences patents Patrick Gillevet Prescient Medicine Series A

RSS Feeds

  • RSS - Posts
  • RSS - Comments

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

Navigation

  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
  • Facebook
  • X
  • RSS

Designed by Elegant Themes | Powered by WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}